Clinical Drug Experience Knowledgebase

Tardive Dyskinesia

Adrenal Hyperplasia, Congenital (Phase 3)

Adrenocortical Hyperfunction (Phase 3)

Adrenogenital Syndrome (Phase 3)

Brain Diseases (Phase 2)

Breast Neoplasms (Phase 1)

Carcinoma, Renal Cell (Phase 1)

Central Nervous System Neoplasms (Phase 2)

Chorea (Phase 3)

Depression (Phase 3)

Depressive Disorder (Phase 3)

Diabetes Mellitus (Phase 1)

Diabetes Mellitus, Type 1 (Phase 1)

Dyskinesias (Phase 4)

Epilepsy (Phase 2)

Glioblastoma (Phase 2)

Hepatic Insufficiency (Phase 1)

Huntington Disease (Phase 3)

Hyperplasia (Phase 3)

Kidney Neoplasms (Phase 1)

Liver Failure (Phase 1)

Lung Neoplasms (Phase 1)

Multiple Sclerosis (Phase 2)

Nervous System Neoplasms (Phase 2)

Parkinson Disease (Phase 1)

Psychotic Disorders (Phase 2)

Schizophrenia (Phase 2)

Sclerosis (Phase 2)

Sleep Initiation and Maintenance Disorders (Phase 3)

Substance Withdrawal Syndrome (Phase 4)

Syndrome (Phase 2)

Tardive Dyskinesia (Phase 4)

Tourette Syndrome (Phase 2)